This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Methotrexate rheumatology guidelines

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Methotrexate is an antifolate drug used in chemotherapy. Its action is to bind dihydrofolate reductase.

It is indicated for the treatment of various malignancies at high dose and for the treatment of psoriasis and rheumatoid arthritis as a titrated weekly dose (1).

The summary of product characteristics should be consulted before prescribing this drug.

Reference:

  • (1) Current Problems in Pharmacovigilance (2000), 26, 10.

Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.